Application of Mesoporous Silica Nanoparticles in Cancer Therapy and Delivery of Repurposed Anthelmintics for Cancer Therapy
This review focuses on the biomedical application of mesoporous silica nanoparticles (MSNs), mainly focusing on the therapeutic application of MSNs for cancer treatment and specifically on overcoming the challenges of currently available anthelmintics (e.g., low water solubility) as repurposed drugs...
Saved in:
Main Authors: | Maedeh Koohi Moftakhari Esfahani (Author), Seyed Ebrahim Alavi (Author), Peter J. Cabot (Author), Nazrul Islam (Author), Emad L. Izake (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PEGylated Mesoporous Silica Nanoparticles (MCM-41): A Promising Carrier for the Targeted Delivery of Fenbendazole into Prostrate Cancer Cells
by: Maedeh Koohi Moftakhari Esfahani, et al.
Published: (2021) -
β-Lactoglobulin-Modified Mesoporous Silica Nanoparticles: A Promising Carrier for the Targeted Delivery of Fenbendazole into Prostate Cancer Cells
by: Maedeh Koohi Moftakhari Esfahani, et al.
Published: (2022) -
Anthelmintics for drug repurposing: Opportunities and challenges
by: Seyed Ebrahim Alavi, et al.
Published: (2021) -
Multimodal Decorations of Mesoporous Silica Nanoparticles for Improved Cancer Therapy
by: Sugata Barui, et al.
Published: (2020) -
Current Stimuli-Responsive Mesoporous Silica Nanoparticles for Cancer Therapy
by: Thashini Moodley, et al.
Published: (2021)